MSN Laboratories to launch favipiravir at Rs 33
The company will be launching it on August 15 under the brand name Favilow
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19
Zydus Cadila launches remdesivir at Rs 2800 per 100 mg vial
To be sold under brand name Remdac, the API for the drug has been developed and manufactured at the company’s API manufacturing…
Pharma units in Sikkim affected by COVID-19, production slashed by 25-30 per cent
Presently, the State has approximately 48 pharma units and around 10 pharma units have been declared as active containment zones…
Stanford study reveals immune-system deviations in severe COVID-19 cases
The study revealed, paradoxically, that the worse the case of COVID-19, the less effective certain cells of the innate immune…
Post-COVID, there will be a mix of various working models
Koki Sato, Country Head and GM, Takeda India talks about the company’s recent drug launch in India, its plans for the Indian…
Remdesivir shortage is India is easing: Cipla
The company has informed that it has started producing remdesivir at a plant in Goa in western India to ramp up production
US signs $1.5 bn deal with Moderna for 100 mn doses of COVID-19 vaccine
Moderna’s deal with the US only pays out in full if the company hits certain unspecific timing benchmarks for vaccine delivery
Gilead seeks full approval for remdesivir from US FDA for COVID-19 treatment
To boost the drug’s availability globally, Gilead has signed multiple manufacturing and supply deals, including with Pfizer and…
IIT Mandi team compares disordered proteins in COVID-19 virus through computational studies
Understanding the structure and functions of intrinsically disordered proteins (IDPs), and intrinsically disordered protein…
Everest Organics develops remdesivir API
The company has plans for the development of more products in the anti-viral segments in the future